What is the PRN (pro re nata) medication used for breakthrough seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PRN Medication for Breakthrough Seizures

Benzodiazepines are the definitive PRN medication for breakthrough seizures, with lorazepam (0.5-2 mg IV/PO every 4-6 hours) being the preferred first-line agent due to its superior efficacy and longer duration of action. 1, 2

First-Line PRN Options

Lorazepam is the gold standard for acute breakthrough seizures:

  • Dosing: 0.5-2 mg IV or PO every 4-6 hours as needed 3
  • Efficacy: 65% success rate in terminating status epilepticus, superior to diazepam (59.1% vs 42.6%) 1, 2
  • Advantages: Longer duration of action compared to other benzodiazepines, making it ideal for preventing seizure recurrence 1, 2

Alternative benzodiazepine options when lorazepam is unavailable:

  • Diazepam: 5-10 mg IV/IM, can be repeated every 3-4 hours 4
  • Midazolam: Particularly useful when IV access is difficult, as IM administration is rapidly absorbed and effective within 5-10 minutes 5, 6
  • Diazepam buccal film: Convenient non-parenteral option that adheres to buccal mucosa and delivers medication rapidly 7

Critical Implementation Points

Route selection matters significantly:

  • IV route is preferred when available for fastest onset 1, 5
  • IM midazolam is equally efficacious to IV lorazepam when IV access is challenging, making it an excellent pre-hospital option 1, 5
  • Rectal diazepam remains an option but is more challenging to administer during active seizures 2, 7

Respiratory monitoring is mandatory:

  • Have airway equipment immediately available before administering any benzodiazepine 1
  • Benzodiazepines may cause hypotension and respiratory depression, requiring continuous vital sign monitoring 1, 5

When Benzodiazepines Fail

If breakthrough seizures continue after adequate benzodiazepine dosing, escalate to second-line agents:

  • Levetiracetam: 30 mg/kg IV (approximately 2000-3000 mg for adults) with 68-73% efficacy 1
  • Valproate: 20-30 mg/kg IV with 88% efficacy and minimal hypotension risk 1
  • Fosphenytoin: 20 mg PE/kg IV, though associated with 12% hypotension risk requiring cardiac monitoring 1

Common Pitfalls to Avoid

Do not use phenytoin for drug-induced seizures - there is no role for phenytoin in this setting, as it is ineffective for most toxic seizures 8

Avoid inadequate dosing - underdosing benzodiazepines is a common error; use full recommended doses (lorazepam 0.5-2 mg, not lower doses) 3

Do not delay treatment - time to treatment is crucial, as clinical response to benzodiazepines is lost with prolonged seizure activity 2

Never use neuromuscular blockers alone - they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 1

Special Considerations

For elderly or debilitated patients: Start with lower benzodiazepine doses (2-5 mg) and increase slowly 4

For women of childbearing potential: If escalating beyond benzodiazepines, avoid valproate due to teratogenicity; prefer levetiracetam 1

Chronic benzodiazepine use concerns: Long-term PRN use carries risks of tolerance, sedation, and potential for addiction 2

References

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Role of Benzodiazepines in the Treatment of Epilepsy.

Current treatment options in neurology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of intramuscular midazolam for status epilepticus.

The Journal of emergency medicine, 1999

Research

Diazepam buccal film for the treatment of acute seizures.

Epilepsy & behavior : E&B, 2019

Research

Treatment of drug-induced seizures.

British journal of clinical pharmacology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.